Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Forte Biosciences Inc (NQ: FBRX ) 0.5239 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 0.5239 Bid (Size) 0.5040 (2) Ask (Size) 0.5800 (1) Prev. Close 0.5239 Today's Range 0.5239 - 0.5239 52wk Range 0.3800 - 1.040 Shares Outstanding 21,051,195 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules May 17, 2024 From Forte Biosciences, Inc. Via Business Wire FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024 May 13, 2024 Forte Biosciences just reported results for the first quarter of 2024. Via InvestorPlace Performance YTD -36.88% -36.88% 1 Month -9.83% -9.83% 3 Month -26.99% -26.99% 6 Month -36.88% -36.88% 1 Year -49.47% -49.47% More News Read More Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update May 13, 2024 From Forte Biosciences, Inc. Via Business Wire FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023 March 19, 2024 Via InvestorPlace Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update March 18, 2024 From Forte Biosciences, Inc. Via Business Wire 12 Health Care Stocks Moving In Friday's After-Market Session December 15, 2023 Via Benzinga Research Frontiers And 3 Other Stocks Under $1 Insiders Are Buying December 13, 2023 Via Benzinga Topics Stocks Exposures US Equities RiskOn International And 3 Other Stocks Under $2 Insiders Are Buying December 11, 2023 Via Benzinga Topics Stocks Exposures US Equities Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules December 01, 2023 From Forte Biosciences, Inc. Via Business Wire Insiders Buying Vintage Wine Estates And 3 Other Stocks Under $1 November 24, 2023 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's After-Market Session November 20, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session November 17, 2023 Via Benzinga Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update November 13, 2023 From Forte Biosciences, Inc. Via Business Wire ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting September 14, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom September 06, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders August 25, 2023 From On behalf of Concerned Stockholders of Forte Via Business Wire Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update August 14, 2023 From Forte Biosciences, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Friday August 04, 2023 Via Benzinga Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102 August 01, 2023 From Forte Biosciences, Inc. Via Business Wire Earnings Scheduled For May 26, 2023 May 26, 2023 Via Benzinga Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules May 19, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update May 15, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update March 31, 2023 From Forte Biosciences, Inc. Via Business Wire Mr. David Gryska Appointed to Forte Biosciences Board of Directors January 12, 2023 From Forte Biosciences, Inc. Via Business Wire Forte Biosciences, Inc. Announces Third Quarter 2022 Results and Provides Business Update November 14, 2022 From Forte Biosciences, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.